Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Calcium and Phosphate Hormones: Vitamin D, Parathyroid Hormone, and Fibroblast Growth Factor 23.

Underland L, Markowitz M, Gensure R.

Pediatr Rev. 2020 Jan;41(1):3-11. doi: 10.1542/pir.2018-0065. No abstract available.

PMID:
31894068
2.

Central Precocious Puberty as a Complication of Therapy with Adrenocorticotropin (ACTH) and an Aromatase Inhibitor for Refractory Nephrotic Syndrome.

Agrawal S, Gensure R, Milner L, Nicoletta J, Sadeghi-Nejad A.

Case Rep Pediatr. 2019 Apr 4;2019:1624274. doi: 10.1155/2019/1624274. eCollection 2019.

3.

Incidence and Outcomes of Pituitary Microadenomas in Children with Short Stature/Growth Hormone Deficiency.

Derrick KM, Gomes WA, Gensure RC.

Horm Res Paediatr. 2018;90(3):151-160. doi: 10.1159/000489456. Epub 2018 Sep 27.

PMID:
30261514
4.

Commentary on the Impact of Obesity on PediatricDiabetes.

Agrawal S, Gensure R.

Clin Ther. 2018 Oct;40(10):1631-1637. doi: 10.1016/j.clinthera.2018.08.006. Epub 2018 Sep 5.

PMID:
30193749
5.

Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Sauer L, Gensure RH, Hammer M, Bernstein PS.

Ophthalmol Retina. 2018 Jun;2(6):587-598. doi: 10.1016/j.oret.2017.10.008. Epub 2017 Dec 8.

6.

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment.

Sauer L, Andersen KM, Li B, Gensure RH, Hammer M, Bernstein PS.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3094-3103. doi: 10.1167/iovs.18-23886.

7.

Patterns of Fundus Autofluorescence Lifetimes In Eyes of Individuals With Nonexudative Age-Related Macular Degeneration.

Sauer L, Gensure RH, Andersen KM, Kreilkamp L, Hageman GS, Hammer M, Bernstein PS.

Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD65-AMD77. doi: 10.1167/iovs.17-23764.

8.

Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).

Andersen KM, Sauer L, Gensure RH, Hammer M, Bernstein PS.

Transl Vis Sci Technol. 2018 Jun 22;7(3):20. doi: 10.1167/tvst.7.3.20. eCollection 2018 Jun.

9.

Short-duration transient visual evoked potentials and color reflectivity discretization analysis in glaucoma patients and suspects.

Waisbourd M, Gensure RH, Aminlari A, Shah SB, Khanna N, Sood N, Molineaux J, Gonzalez A, Myers JS, Katz LJ.

Int J Ophthalmol. 2017 Feb 18;10(2):254-261. doi: 10.18240/ijo.2017.02.12. eCollection 2017.

10.

Parathyroid Disorders.

Markowitz ME, Underland L, Gensure R.

Pediatr Rev. 2016 Dec;37(12):524-535. Review. No abstract available.

PMID:
27909107
11.

COAGULASE-NEGATIVE STAPHYLOCOCCUS-INDUCED FROSTED BRANCH ANGIITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION.

Gensure RH, Hsu J, Federman J, Park C, Spirn MJ.

Retin Cases Brief Rep. 2017 Winter;11(1):60-62. doi: 10.1097/ICB.0000000000000288.

PMID:
26954782
12.

Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents: A Randomized Clinical Trial.

Talib HJ, Ponnapakkam T, Gensure R, Cohen HW, Coupey SM.

J Pediatr. 2016 Mar;170:266-72.e1. doi: 10.1016/j.jpeds.2015.11.025. Epub 2015 Dec 18.

13.

Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.

Katikaneni R, Seymour AW, Gulati R, Ponnapakkam T, Gensure RC.

J Investig Dermatol Symp Proc. 2015 Nov;17(2):13-5. doi: 10.1038/jidsymp.2015.32.

14.

A new technique for quantitative analysis of hair loss in mice using grayscale analysis.

Ponnapakkam T, Katikaneni R, Gulati R, Gensure R.

J Vis Exp. 2015 Mar 9;(97). doi: 10.3791/52185.

15.

Content-based histopathology image retrieval using CometCloud.

Qi X, Wang D, Rodero I, Diaz-Montes J, Gensure RH, Xing F, Zhong H, Goodell L, Parashar M, Foran DJ, Yang L.

BMC Bioinformatics. 2014 Aug 26;15:287. doi: 10.1186/1471-2105-15-287.

16.

Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth?

Gensure RC.

Exp Dermatol. 2014 Dec;23(12):865-7. doi: 10.1111/exd.12504. Review.

PMID:
25041375
17.

Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.

Katikaneni R, Ponnapakkam T, Seymour A, Sakon J, Gensure R.

Anticancer Drugs. 2014 Aug;25(7):819-25. doi: 10.1097/CAD.0000000000000110.

18.

Pharmacokinetics in rats of a long-acting human parathyroid hormone-collagen binding domain peptide construct.

Stratford R Jr, Vu C, Sakon J, Katikaneni R, Gensure R, Ponnapakkam T.

J Pharm Sci. 2014 Feb;103(2):768-75. doi: 10.1002/jps.23843. Epub 2014 Jan 7.

19.

Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.

Carpizo DR, Gensure RH, Yu X, Gendel VM, Greene SJ, Moore DF, Jabbour SK, Nosher JL.

J Vasc Interv Radiol. 2014 Feb;25(2):297-306.e1. doi: 10.1016/j.jvir.2013.10.030. Epub 2013 Dec 20.

20.

Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain.

Katikaneni R, Gulati R, Suh D, Sakon J, Seymour A, Ponnapakkam T, Gensure R.

J Investig Dermatol Symp Proc. 2013 Dec;16(1):S61-2. doi: 10.1038/jidsymp.2013.25.

21.

Clinical response to combined therapy of cyclosporine and prednisone.

Gensure RC.

J Investig Dermatol Symp Proc. 2013 Dec;16(1):S58. doi: 10.1038/jidsymp.2013.23.

22.

Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.

Katikaneni R, Ponnapakkam T, Matsushita O, Sakon J, Gensure R.

Anticancer Drugs. 2014 Jan;25(1):30-8. doi: 10.1097/CAD.0b013e3283650bff.

23.

Treating osteoporosis by targeting parathyroid hormone to bone.

Ponnapakkam T, Katikaneni R, Sakon J, Stratford R, Gensure RC.

Drug Discov Today. 2014 Mar;19(3):204-8. doi: 10.1016/j.drudis.2013.07.015. Epub 2013 Aug 6.

24.

Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.

Schonewolf CA, Patel B, Gensure RH, Narra V, Haffty BG, Nosher JL, Jabbour SK.

Am J Clin Oncol. 2014 Jun;37(3):234-40. doi: 10.1097/COC.0b013e318277d610.

PMID:
23275270
25.

Evaluation of hepatic tumor response to yttrium-90 radioembolization therapy using texture signatures generated from contrast-enhanced CT images.

Gensure RH, Foran DJ, Lee VM, Gendel VM, Jabbour SK, Carpizo DR, Nosher JL, Yang L.

Acad Radiol. 2012 Oct;19(10):1201-7. doi: 10.1016/j.acra.2012.04.015. Epub 2012 Jul 26.

26.

A single injection of the anabolic bone agent, parathyroid hormone-collagen binding domain (PTH-CBD), results in sustained increases in bone mineral density for up to 12 months in normal female mice.

Ponnapakkam T, Katikaneni R, Suda H, Miyata S, Matsushita O, Sakon J, Gensure RC.

Calcif Tissue Int. 2012 Sep;91(3):196-203. doi: 10.1007/s00223-012-9626-1. Epub 2012 Jul 18.

27.

Reversed seasonal variation in maternal vitamin D levels in southern Louisiana.

Gangat M, Ponnapakkam T, Bradford E, Katikaneni R, Gensure R.

Clin Pediatr (Phila). 2012 Aug;51(8):718-22. doi: 10.1177/0009922812444599. Epub 2012 May 7.

PMID:
22566707
28.

Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.

Katikaneni R, Ponnapakkam T, Suda H, Miyata S, Sakon J, Matsushita O, Gensure RC.

Int J Cancer. 2012 Sep 1;131(5):E813-21. doi: 10.1002/ijc.27379. Epub 2012 Jan 24.

29.

Prevention of chemotherapy-induced osteoporosis by cyclophosphamide with a long-acting form of parathyroid hormone.

Ponnapakkam T, Katikaneni R, Nichols T, Tobin G, Sakon J, Matsushita O, Gensure RC.

J Endocrinol Invest. 2011 Dec;34(11):e392-7. doi: 10.3275/7864. Epub 2011 Jul 12.

PMID:
21750397
30.

Association of flat feet with knee pain and cartilage damage in older adults.

Gross KD, Felson DT, Niu J, Hunter DJ, Guermazi A, Roemer FW, Dufour AB, Gensure RH, Hannan MT.

Arthritis Care Res (Hoboken). 2011 Jul;63(7):937-44. doi: 10.1002/acr.20431.

31.

Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in mice.

Ponnapakkam T, Katikaneni R, Miller E, Ponnapakkam A, Hirofumi S, Miyata S, Suva LJ, Sakon J, Matsushita O, Gensure RC.

Calcif Tissue Int. 2011 Jun;88(6):511-20. doi: 10.1007/s00223-011-9485-1. Epub 2011 Apr 22.

PMID:
21512758
32.

A treatment trial of vitamin D supplementation in breast-fed infants: universal supplementation is not necessary for rickets prevention in Southern Louisiana.

Ponnapakkam T, Bradford E, Gensure R.

Clin Pediatr (Phila). 2010 Nov;49(11):1053-60. doi: 10.1177/0009922810376320. Epub 2010 Aug 19.

PMID:
20724336
33.

A new technique for precisely and accurately measuring lumbar spine bone mineral density in mice using clinical dual energy X-ray absorptiometry (DXA).

Katikaneni R, Ponnapakkam A, Miller E, Ponnapakkam T, Gensure RC.

Toxicol Mech Methods. 2009 Mar;19(3):225-31. doi: 10.1080/15376510802499030.

34.

Ca2+-induced linker transformation leads to a compact and rigid collagen-binding domain of Clostridium histolyticum collagenase.

Philominathan ST, Matsushita O, Gensure R, Sakon J.

FEBS J. 2009 Jul;276(13):3589-601. doi: 10.1111/j.1742-4658.2009.07078.x. Epub 2009 May 28.

35.

Breastfeeding does not protect against urinary tract infection in the first 3 months of life, but vitamin D supplementation increases the risk by 76%.

Katikaneni R, Ponnapakkam T, Ponnapakkam A, Gensure R.

Clin Pediatr (Phila). 2009 Sep;48(7):750-5. doi: 10.1177/0009922809332588. Epub 2009 Mar 4.

PMID:
19264720
36.

Breast-feeding and Vitamin D Supplementation Rates in the Ochsner Health System.

Ponnapakkam T, Ravichandran A, Bradford E, Tobin G, Gensure R.

Ochsner J. 2008 Fall;8(3):146-50.

37.
38.
39.

A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Gensure RC, Mäkitie O, Barclay C, Chan C, Depalma SR, Bastepe M, Abuzahra H, Couper R, Mundlos S, Sillence D, Ala Kokko L, Seidman JG, Cole WG, Jüppner H.

J Clin Invest. 2005 May;115(5):1250-7.

40.

A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS.

Linglart A, Gensure RC, Olney RC, Jüppner H, Bastepe M.

Am J Hum Genet. 2005 May;76(5):804-14. Epub 2005 Mar 30. Erratum in: Am J Hum Genet. 2007 Jul;81(1):196.

41.

Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

Gensure RC, Gardella TJ, Jüppner H.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):666-78. Review.

PMID:
15694400
42.

Parathyroid hormone without parathyroid glands.

Gensure R, Jüppner H.

Endocrinology. 2005 Feb;146(2):544-6. Review. No abstract available.

PMID:
15649970
43.

Identification and characterization of the zebrafish and fugu genes encoding tuberoinfundibular peptide 39.

Papasani MR, Gensure RC, Yan YL, Gunes Y, Postlethwait JH, Ponugoti B, John MR, Jüppner H, Rubin DA.

Endocrinology. 2004 Nov;145(11):5294-304. Epub 2004 Aug 5.

PMID:
15297442
44.

Haplotype frequencies and linkage disequilibrium analysis of four frequent polymorphisms at the PTH/PTH-related peptide receptor gene locus.

Fröhlich LF, Gensure RC, Schipani E, Jüppner H, Bastepe M.

Mol Cell Probes. 2004 Oct;18(5):353-7.

PMID:
15294324
45.

Permeabilities of teleost and elasmobranch gill apical membranes: evidence that lipid bilayers alone do not account for barrier function.

Hill WG, Mathai JC, Gensure RH, Zeidel JD, Apodaca G, Saenz JP, Kinne-Saffran E, Kinne R, Zeidel ML.

Am J Physiol Cell Physiol. 2004 Jul;287(1):C235-42. Epub 2004 Mar 3.

46.

Identification and characterization of two parathyroid hormone-like molecules in zebrafish.

Gensure RC, Ponugoti B, Gunes Y, Papasani MR, Lanske B, Bastepe M, Rubin DA, Jüppner H.

Endocrinology. 2004 Apr;145(4):1634-9. Epub 2003 Dec 18.

PMID:
14684608
47.
48.

A mutant PTH/PTHrP type I receptor in enchondromatosis.

Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG, Bell RS, Jüppner H, Andrulis IL, Wunder JS, Alman BA.

Nat Genet. 2002 Mar;30(3):306-10. Epub 2002 Feb 19.

PMID:
11850620
49.

Supplemental Content

Loading ...
Support Center